Page last updated: 2024-10-21

3-methylcholanthrene and Insulin Resistance

3-methylcholanthrene has been researched along with Insulin Resistance in 2 studies

Methylcholanthrene: A carcinogen that is often used in experimental cancer studies.
3-methylcholanthrene : A pentacyclic ortho- and peri-fused polycyclic arene consisting of a dihydrocyclopenta[ij]tetraphene ring system with a methyl substituent at the 3-position.

Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Noguchi, Y2
Yoshikawa, T2
Nomura, K2
Tsuburaya, A2
Fukuzawa, K2
Makino, T2
Matsumoto, A2

Other Studies

2 other studies available for 3-methylcholanthrene and Insulin Resistance

ArticleYear
[Insulin resistance and fat metabolism in the tumor-bearing state: preliminary report].
    Nihon Geka Gakkai zasshi, 1994, Volume: 95, Issue:2

    Topics: Animals; Blood Glucose; Insulin Resistance; Lipoprotein Lipase; Methylcholanthrene; Rats; Rats, Inbr

1994
Role of insulin resistance in decreasing lipoprotein lipase activity in tumor-bearing rats.
    Surgery today, 1996, Volume: 26, Issue:4

    Topics: Animals; Blood Glucose; Cachexia; Insulin; Insulin Resistance; Lipoprotein Lipase; Male; Methylchola

1996